Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

PROB:SS

109.2500 SEK 0.5000 0.46%

As of 11:32:33 ET on 04/01/2015.

Snapshot for Probi AB (PROB)

Open: 108.7500 Day's Range: 107.5000 - 109.2500 Volume: 8,948
Previous Close: 108.7500 52wk Range: 39.9000 - 112.5000 1-Yr Rtn: +178.04%

Stock Chart for PROB

No chart data available.
  • PROB:SS 109.2500
  • 1D
  • 1M
  • 1Y
108.7500
Interactive PROB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PROB

Current P/E Ratio (ttm) 45.9034
Estimated P/E(12/2015) 34.5728
Relative P/E vs. OMX 2.5747
Earnings Per Share (SEK) (ttm) 2.3800
Est. EPS (SEK) (12/2015) 3.1600
Est. PEG Ratio -
Market Cap (M SEK) 1,023.16
Shares Outstanding (M) 9.37
30 Day Average Volume 10,022
Price/Book (mrq) 6.6359
Price/Sale (ttm) 7.3634
Dividend Indicated Gross Yield 0.78%
Cash Dividend (SEK) 0.8500
Dividend Ex-Date 04/24/2015
5 Year Dividend Growth -
Next Earnings Announcement 04/23/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PROB

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for PROB

Probi AB carries out research and development in probiotics. The Company has three main research areas: surgery and medicine, foodstuff technology, and microbiology. Probi has developed the fruit drink ProViva, containing active bioculture intended to counteract harmful bacteria and strengthen the immune system. The Company also develops animal feed. Probi markets internationally.

Peter NaehlstedtChief Executive OfficerNiklas BrandtChief Financial Officer
Niklas BjaerumVP:Marketing & SalesGun Britt FranssonVP:Research&Development
More Company Profile & Key Executives for PROB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil